Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sagi

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
The Journal of Biological Chemistry|August 27, 2011
Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor proteinSarah A Sagi, Christian B Lessard, Kellen D Winden, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2006
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664Veronica Galvan, Olivia F Gorostiza, Surita Banwait, et al.
Journal of Neurochemistry|November 23, 2005
Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42Stefanie Leuchtenberger, Markus P Kummer, Thomas Kukar, et al.
The Journal of Clinical Investigation|August 5, 2003
NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivoJason L Eriksen, Sarah A Sagi, Tawnya E Smith, et al.
Alzheimer Disease and Associated Disorders|December 20, 2007
Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individualsDouglas R Galasko, Neil Graff-Radford, Susanne May, et al.
Nature|November 9, 2001
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activityS Weggen, J L Eriksen, P Das, et al.
Nature Medicine|April 19, 2005
Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 productionThomas Kukar, Michael Paul Murphy, Jason L Eriksen, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
The Journal of Biological Chemistry|August 27, 2011
Substrate sequence influences γ-secretase modulator activity, role of the transmembrane domain of the amyloid precursor proteinSarah A Sagi, Christian B Lessard, Kellen D Winden, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2006
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664Veronica Galvan, Olivia F Gorostiza, Surita Banwait, et al.
Journal of Neurochemistry|November 23, 2005
Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42Stefanie Leuchtenberger, Markus P Kummer, Thomas Kukar, et al.
The Journal of Clinical Investigation|August 5, 2003
NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivoJason L Eriksen, Sarah A Sagi, Tawnya E Smith, et al.
Alzheimer Disease and Associated Disorders|December 20, 2007
Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individualsDouglas R Galasko, Neil Graff-Radford, Susanne May, et al.
Nature|November 9, 2001
A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activityS Weggen, J L Eriksen, P Das, et al.
Nature Medicine|April 19, 2005
Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 productionThomas Kukar, Michael Paul Murphy, Jason L Eriksen, et al.
Pageof 12